Processa Pharmaceuticals, Inc. (PCSA) CEO receives 9,384 RSUs grant
Rhea-AI Filing Summary
Processa Pharmaceuticals, Inc. granted Chief Executive Officer George K. Ng 9,384 Restricted Stock Units on July 26, 2026. Each RSU equals one common share, vested immediately, with settlement deferred until termination, six months after grant, a change of control, or death.
After this award, Ng directly holds 21,224 RSUs, stock options for 30,720 shares at an exercise price of $4.96 per share, and additional direct and indirect common stock holdings; all reported share amounts reflect a 1-for-25 reverse stock split effected on December 17, 2025.
Positive
- None.
Negative
- None.
Insider Trade Summary
5 transactions reported
Mixed
5 txns
Insider
Ng George K
Role
Chief Executive Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Restricted Stock Units F1, F3 | 9,384 | $0.00 | $0.00 |
| holding | Stock Options (Right to Buy) F2, F3 | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Restricted Stock Units — 21,224 shares (Direct);
Stock Options (Right to Buy) — 30,720 shares (Direct);
Common Stock — 15,492 shares (Direct);
Common Stock — 3,488 shares (Indirect, George Ng IRRA FOB George Ng);
Common Stock — 800 shares (Indirect, Ng Cha Family Trust)
Footnotes (3)
- F1. Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock. These RSUs vested upon grant, but will not be distributed until the earlier of: (i) their termination; (ii) six month anniversary of the grant date; (iii) change of control; or (iv) their death.
- F2. Stock options vest one-third on the first anniversary date of the grant, with the remaining options vesting ratably over the subsequent two years.
- F3. Reflects the 1-for-25 reverse stock split effected by the Issuer on December 17, 2025.
Key Figures
Restricted Stock Units granted: 9,384 units
RSUs held after grant: 21,224 units
Stock option exercise price: $4.96 per share
+5 more
8 metrics
Restricted Stock Units granted
9,384 units
Grant to CEO George K. Ng on July 26, 2026
RSUs held after grant
21,224 units
Total direct RSU holdings of George K. Ng after transaction
Stock option exercise price
$4.96 per share
Exercise price for options over Processa common stock
Underlying option shares
30,720 shares
Common shares underlying stock options held directly
Direct common shares
15,492 shares
Processa common stock held directly by George K. Ng
Indirect IRRA shares
3,488 shares
Common stock held indirectly via George Ng IRRA FOB George Ng
Indirect trust shares
800 shares
Common stock held indirectly via Ng Cha Family Trust
Reverse stock split ratio
1-for-25
Reverse split effected on December 17, 2025
Key Terms
Restricted Stock Units, Stock Options (Right to Buy, 1-for-25 reverse stock split, change of control
4 terms
Restricted Stock Units financial
"Each Restricted Stock Unit represents a contingent right to receive one share"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
Stock Options (Right to Buy financial
"Stock Options (Right to Buy) with an exercise price of $4.9600 per share"
1-for-25 reverse stock split financial
"Reflects the 1-for-25 reverse stock split effected on December 17, 2025"
change of control financial
"settled upon termination, six months after grant, change of control, or death"
A change of control occurs when the ownership or management of a company shifts significantly, such as through a sale, merger, or acquisition, resulting in new leadership or ownership structure. This change can impact the company's direction and decision-making, which is important for investors because it may affect the company's stability, strategy, and future prospects.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What equity award did Processa (PCSA) CEO George K. Ng receive in this insider report?
George K. Ng received 9,384 Restricted Stock Units on July 26, 2026. Each RSU equals one common share, vested upon grant, with settlement deferred until the earlier of termination, six months after grant, a change of control, or death.
How many Restricted Stock Units does PCSA CEO George Ng hold after the reported transaction?
Following the grant, George K. Ng holds 21,224 Restricted Stock Units directly. These RSUs each represent a contingent right to receive one share of Processa Pharmaceuticals common stock, subject to the stated distribution conditions.
Were George Ng’s PCSA equity transactions made under a Rule 10b5-1 trading plan?
The report’s Rule 10b5-1 checkbox is not marked as relying on a plan. This indicates the reported equity grant and holdings are not affirmed as being executed under a pre-arranged Rule 10b5-1 trading plan.